15 Jul 2026
This webinar will explore the necessity, challenges and advancements of microsampling in both preclinical and clinical bioanalysis. Microsampling has the potential to enhance patient experience, support the 3R principles, enable decentralized clinical trials and allow more frequent assessment of bioanalytical drug effects. While the benefits are compelling, challenges such as sample integrity, capillary vs. venous comparisons, bridging studies and regulatory acceptance have previously limited broad adoption.
Featured Speakers
James Tunaley, PhD
Study Director & Scientist, Molecular Bioanalysis
Alexandra Bushby
Method Development Scientist, LC–MS
What You’ll Learn
Evolving trends supporting the need for microsampling in preclinical and clinical bioanalysis
Challenges across small molecules, large molecules and molecular modalities
Approaches and advancements across a wide variety of bioanalytical modalities
Expert predictions on the future of microsampling within bioanalysis